| NCT06841315 | A Varegacestat Hepatic Impairment Study | RECRUITING | PHASE1 | 2025-03-07 | 2025-12 | 2025-11 |
| NCT06823167 | A Phase 1 Study of IM-1021 in Participants With Advanced Cancer | RECRUITING | PHASE1 | 2025-02-26 | 2029-02 | 2028-05 |
| NCT06845852 | A Phase 1 Mass Balance Study of Varegacestat | COMPLETED | PHASE1 | 2025-02-25 | 2025-03-26 | 2025-03-11 |
| NCT06855264 | A Cardiac Liability Study of Varegacestat in Healthy Participants | COMPLETED | PHASE1 | 2025-02-24 | 2025-05-06 | 2025-04-08 |
| NCT06677996 | A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants | COMPLETED | PHASE1 | 2024-11-11 | 2025-05-07 | 2024-12-30 |
| NCT05429021 | IMM-BCP-01 in Mild to Moderate COVID-19 | TERMINATED | PHASE1 | 2022-06-03 | 2023-01-06 | 2023-01-06 |
| NCT04871282 | A Study of AL102 in Patients With Progressing Desmoid Tumors | ACTIVE_NOT_RECRUITING | PHASE2, PHASE3 | 2021-03-30 | 2026-10 | 2025-10 |